28
What are we talking about ? •A disease that affects ALL children before the age of 5 years •Responsible for 5 % deaths of all children less than 5 years.

Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Embed Size (px)

DESCRIPTION

Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs with specific reference to India.

Citation preview

Page 1: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

What are we talking about ?

• A disease that affects ALL children before the age of 5 years

• Responsible for 5 % deaths of all children less than 5 years.

Page 2: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Rotavirus – in 4 parts

Dr Gaurav GuptaCharak Clinics

www.charakclinics.comDCH, DNB, MAAP, MIAP

Page 3: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Rotavirus – the 4 parts

1. Virology – boring yet interesting !

2. Scary Statistics about Rotavirus – the Indian connection

3. Can we clinically identify Rotavirus Diarrhea

4. Preventing Rotavirus Diarrhea – what GSK wants me to talk about

Page 4: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Rotavirus Virology – Part 1

• Rota – means wheel-like in greek• Double-stranded RNA virus

Page 5: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Rotavirus – this is how it looks!Rotavirus – this is how it looks!

Page 6: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs
Page 7: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Rotavirus Virology

• VERY resistant to destruction (Why is this important?)

• VP4 antigen: P serotype; 11 human rotaviruses

• VP7 antigen: G serotype; 10 human rotaviruses

• Commonly found strains:P[8]G1; P[8]G3; P[8]G4; and P[4]G2

Page 8: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Global distribution of human group A rotavirus P-G types (1989-2004)

http://www.cdc.gov/ncidod/EID/vol4no4/parasharG.htm#fig%204)

Other P[6]G8 Africa P[8]G5 Brazil P[11]G10 India P[6]G12 India

Page 9: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Are these multiple serotypes important ?

NOT REALLY !

Because Natural RV infection attenuates

severity of subsequent infections, regardless

of serotype

Page 10: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Cumulative probability of rotavirus infection in 200 Mexican infants during the 1st 2 years of life

1.01.0

0.90.9

0.80.8

0.70.7

0.60.6

0.50.5

0.40.4

0.30.3

0.20.2

0.10.1

11 22 33 44 55 66 77 88 99 1010 1111 1212 1313 1414 1515 1616 1717 1818 1919 2020 2121 2222 2323 2424

Pro

bab

ility

of

rota

viru

s in

fect

ion

Pro

bab

ility

of

rota

viru

s in

fect

ion

Age (months)Age (months)

1st infection1st infection

2nd infection2nd infection

3rd infection3rd infection

4th infection4th infection

5th infection5th infection

*

*Complete protection againstmoderate-to-severe diarrhoea

NEJM 1996; 335: 1022

Page 11: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Scary Statistics– Part 2

• Diarrhoea is third largest cause of death in under 5

• Rotavirus are the single most important cause of diarrhoea worldwide.• Annually rotaviruses

cause – 5% of all deaths in

children– 527,000 deaths

• 80% of deaths are in infancy

• > 100,000 in India– 39% of childhood hospitalisations for

diarrheaLancet Infect Dis 2007; 7: 56 Wkly Epidemiol Rec 2007; 82: 285 JID 2005; 192(Suppl 1) S1 EID 2006;12: 304

Page 12: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs
Page 13: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs
Page 14: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Modified after Emerg Infect Dis 2006; 12: 304

5 million clinic visits

25 million domiciliaryepisodes

1 : 250

1 : 65

EventRisk of Particular Event

100,000 deaths

0.4 million hospitalisations

1 : 5

1 : 1

Estimated prevalence of rotavirus disease in India

Page 15: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs
Page 16: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Part 3 - Can we clinically diagnose Rotavirus gastroenteritis (RVGE)?

• High fever and vomiting in a 6 month to 2 year child

• Severe vomiting resistant to anti-emetics

• Followed by explosive diarrhea, severe with significant peri-anal excoriation

• The diarrhea can be mild to severe and generally lasts 3-9 days. Illness usually begins 3 days after exposure.

Page 17: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

When is a Viral GE unlikely?

• Blood / WBCs in the stool

• Persistent high fever

• Persistent severe bilious vomit without diarrhea

Page 18: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs
Page 19: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Part 4 – Preventing rotavirus

• Democratic Virus – affects the entire world equally, without differentiating the rich & poor – almost 40 % of hospital admissions worldwide due to diarrhea are due to RVGE.

• Hand-washing and sanitation does not work due to the resistant nature of the virus.

• Vaccine works well

Page 20: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Vaccine development

• Goals of a rotavirus vaccine

– Aim to duplicate the degree of protection following natural infection

– Prevent moderate to severe disease• Decrease numbers of children:

– Dying from rotavirus disease– Admitted to hospital– Presenting to health care

facilities» Hospital» Community

Page 21: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

What vaccines are available?

• Rotashield (Wyeth) – Available in 1998, Animal Rhesus Monkey strain, withdrawn after 1 year due to clustering of cases of Intussusception.

• Rotateq (Merck) – Pentavalent Bovine Live Attenuated vaccine.

• > 70,000 subjects• Predominantly in the United States and

Finland• No evidence for increased risk of

intussusception

Page 22: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Vaccines based upon human rotaviruses

• A live-attenuated monovalent human rotavirus vaccine (RotarixR) P[8]G1

– > 63,000 infants– Predominantly in 11 countries from Latin America– No evidence for increased risk of intussusception

– Efficacy for rotavirus disease• 85% against severe rotavirus disease (81% after 1 dose)• 100% against the most severe dehydrating episodes

• Protective efficacy against severe disease– Homotypic G1 serotype 92%– Homotypic P[8] non-G1 serotype 88%

NEJM 2006; 354: 11

Page 23: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

RotarixR RotaTeqTM

Origin Human monovalent P[8]G1

Bovine-human pentavalent

P[8] G1-G4

Oral doses 2 3

Efficacy (95% CI)

any disease

severe

hospitalisation

Severe disease (95% CI)

G1

G2

G3

G4

G9

All cause gastro admissions

N = 20,169

ND

85 (72,92)

85 (70,94)

92 (74,98)

41 (-72,94)

88 (8,100)

-

91 (62,99)

42 (29,53)

N = 68,038

74 (67,79)

95 (91,97)

96 (90,98)

95 (92,97)

88 (<0,99)

93 (49,99)

89 (52,98)

100 (67,100)

59 (52,65)

Post 1st dose shedding 50-80% 9%NEJM 2006; 354: 11 + 23

Page 24: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Other vaccine candidates

• Human-bovine reassortants– Bovine rotavirus tetravalent (BRV-TV) vaccine: G1-G4

• Adding G8 + G9• Brazil, China and India

– Naturally occurring human-bovine reassortants• Delhi (116E) neonatal strain P[10]G9 single bovine VP4 gene• Vellore (I321) neonatal strain P[11]G10

– Bovine strain with 2 human-derived NSPs» Recently shown to be non-protective

• Human neonatal rotavirus strains– Some strains appear naturally attenuated and protective– Melbourne neonatal RV3 strain P[6]G3

• Low immunogenecity, but protective against disease in a small study JID 2006; 194: 370 Vaccine 2006; 24: 5817 Vaccine 2002; 20: 2950

Page 25: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Cost Effectiveness of Rota Vaccine

• A CMC Vellore study shows that average diarrhea hospitalization costs Rs. 4,000/- to 5,000/-

• Rotavirus is a dehydrating diarrhea, with significant chances of doctor visit and hospitalization.

• Vaccine is almost 90-100 % effective against severe RV diarrhea & hospitalization.

Page 26: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Remember …..

• Largest number of death in the WORLD due to Rotavirus occur in India. (More than 300 children/ day)

• ORS is less likely to be effective in Rotavirus, due to increased tendency for vomiting, and destruction of intestinal villi by RV causing malabsorption of glucose, sodium and potassium.

Page 27: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Common Questions1. What is the maximum age for first

dose?

2. What if the child vomits?

3. Can it be given with OPV/ Breast feed/ other vaccines?

4. How to best administer the vaccine?

5. Can Rotarix cause Intussusception?

6. Can we give one dose in children between 5-6 month? After 6 months?

7. How to counsel parents regarding this vaccine?

8. What are the contraindications for Rotavirus vaccine?

Page 28: Rotavirus - Simplified Virology, Statistics, Symptoms, Vaccination & Common FAQs

Let us ERADICATE

the thought of viral

diarrhea